300 related articles for article (PubMed ID: 23388133)
1. Rac3 induces a molecular pathway triggering breast cancer cell aggressiveness: differences in MDA-MB-231 and MCF-7 breast cancer cell lines.
Gest C; Joimel U; Huang L; Pritchard LL; Petit A; Dulong C; Buquet C; Hu CQ; Mirshahi P; Laurent M; Fauvel-Lafève F; Cazin L; Vannier JP; Lu H; Soria J; Li H; Varin R; Soria C
BMC Cancer; 2013 Feb; 13():63. PubMed ID: 23388133
[TBL] [Abstract][Full Text] [Related]
2. Rac1 and Rac3 isoform activation is involved in the invasive and metastatic phenotype of human breast cancer cells.
Baugher PJ; Krishnamoorthy L; Price JE; Dharmawardhane SF
Breast Cancer Res; 2005; 7(6):R965-74. PubMed ID: 16280046
[TBL] [Abstract][Full Text] [Related]
3. Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-κB signaling pathways.
Ahmad A; Wang Z; Kong D; Ali R; Ali S; Banerjee S; Sarkar FH
Breast Cancer Res Treat; 2011 Feb; 126(1):15-25. PubMed ID: 20379844
[TBL] [Abstract][Full Text] [Related]
4. A splice variant of CD99 increases motility and MMP-9 expression of human breast cancer cells through the AKT-, ERK-, and JNK-dependent AP-1 activation signaling pathways.
Byun HJ; Hong IK; Kim E; Jin YJ; Jeoung DI; Hahn JH; Kim YM; Park SH; Lee H
J Biol Chem; 2006 Nov; 281(46):34833-47. PubMed ID: 16984917
[TBL] [Abstract][Full Text] [Related]
5. VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin.
Luo M; Hou L; Li J; Shao S; Huang S; Meng D; Liu L; Feng L; Xia P; Qin T; Zhao X
Cancer Lett; 2016 Apr; 373(1):1-11. PubMed ID: 26805761
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cell invasion and migration by targeting matrix metalloproteinase-9 expression via sirtuin 6 silencing in human breast cancer cells.
Hong OY; Jang HY; Lee YR; Jung SH; Youn HJ; Kim JS
Sci Rep; 2022 Jul; 12(1):12125. PubMed ID: 35840633
[TBL] [Abstract][Full Text] [Related]
7. Clusterin confers resistance to TNF-alpha-induced apoptosis in breast cancer cells through NF-kappaB activation and Bcl-2 overexpression.
Wang Y; Wang X; Zhao H; Liang B; Du Q
J Chemother; 2012 Dec; 24(6):348-57. PubMed ID: 23174100
[TBL] [Abstract][Full Text] [Related]
8. Gonadotropin-releasing hormone receptor activates GTPase RhoA and inhibits cell invasion in the breast cancer cell line MDA-MB-231.
Aguilar-Rojas A; Huerta-Reyes M; Maya-Núñez G; Arechavaleta-Velásco F; Conn PM; Ulloa-Aguirre A; Valdés J
BMC Cancer; 2012 Nov; 12():550. PubMed ID: 23176180
[TBL] [Abstract][Full Text] [Related]
9. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.
Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A
Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089
[TBL] [Abstract][Full Text] [Related]
11. Blockade of Rac1 activity induces G1 cell cycle arrest or apoptosis in breast cancer cells through downregulation of cyclin D1, survivin, and X-linked inhibitor of apoptosis protein.
Yoshida T; Zhang Y; Rivera Rosado LA; Chen J; Khan T; Moon SY; Zhang B
Mol Cancer Ther; 2010 Jun; 9(6):1657-68. PubMed ID: 20515940
[TBL] [Abstract][Full Text] [Related]
12. Lunasin suppresses the migration and invasion of breast cancer cells by inhibiting matrix metalloproteinase-2/-9 via the FAK/Akt/ERK and NF-κB signaling pathways.
Jiang Q; Pan Y; Cheng Y; Li H; Liu D; Li H
Oncol Rep; 2016 Jul; 36(1):253-62. PubMed ID: 27175819
[TBL] [Abstract][Full Text] [Related]
13. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
[TBL] [Abstract][Full Text] [Related]
14. CD24 enhances DNA damage-induced apoptosis by modulating NF-κB signaling in CD44-expressing breast cancer cells.
Ju JH; Jang K; Lee KM; Kim M; Kim J; Yi JY; Noh DY; Shin I
Carcinogenesis; 2011 Oct; 32(10):1474-83. PubMed ID: 21798852
[TBL] [Abstract][Full Text] [Related]
15. BLT2 up-regulates interleukin-8 production and promotes the invasiveness of breast cancer cells.
Kim H; Choi JA; Park GS; Kim JH
PLoS One; 2012; 7(11):e49186. PubMed ID: 23145117
[TBL] [Abstract][Full Text] [Related]
16. ShRNA-mediated gene silencing of MTA1 influenced on protein expression of ER alpha, MMP-9, CyclinD1 and invasiveness, proliferation in breast cancer cell lines MDA-MB-231 and MCF-7 in vitro.
Jiang Q; Zhang H; Zhang P
J Exp Clin Cancer Res; 2011 May; 30(1):60. PubMed ID: 21595884
[TBL] [Abstract][Full Text] [Related]
17. Induction of heme oxygenase-1 and inhibition of TPA-induced matrix metalloproteinase-9 expression by andrographolide in MCF-7 human breast cancer cells.
Chao CY; Lii CK; Hsu YT; Lu CY; Liu KL; Li CC; Chen HW
Carcinogenesis; 2013 Aug; 34(8):1843-51. PubMed ID: 23615401
[TBL] [Abstract][Full Text] [Related]
18. Epigallocatechin-3-gallate (EGCG) downregulates gelatinase-B (MMP-9) by involvement of FAK/ERK/NFkappaB and AP-1 in the human breast cancer cell line MDA-MB-231.
Sen T; Dutta A; Chatterjee A
Anticancer Drugs; 2010 Jul; 21(6):632-44. PubMed ID: 20527725
[TBL] [Abstract][Full Text] [Related]
19. Silencing of D4-GDI inhibits growth and invasive behavior in MDA-MB-231 cells by activation of Rac-dependent p38 and JNK signaling.
Zhang Y; Rivera Rosado LA; Moon SY; Zhang B
J Biol Chem; 2009 May; 284(19):12956-65. PubMed ID: 19269969
[TBL] [Abstract][Full Text] [Related]
20. Curcumol Suppresses Breast Cancer Cell Metastasis by Inhibiting MMP-9 Via JNK1/2 and Akt-Dependent NF-κB Signaling Pathways.
Ning L; Ma H; Jiang Z; Chen L; Li L; Chen Q; Qi H
Integr Cancer Ther; 2016 Jun; 15(2):216-25. PubMed ID: 27125675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]